100 Participants Needed

Speech-Language Therapy for Aphasia

(TERRA Trial)

Recruiting at 2 trial locations
HA
LA
SS
KP
Overseen ByKelli Powell, B.S.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of South Carolina
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the effectiveness of remotely delivered speech-language therapy compared to traditional in-clinic sessions for people with aphasia, a condition that affects communication skills after a stroke. Participants will engage in both semantically-focused (meaning-based) and phonologically-focused (sound-based) therapy tasks. The trial aims to determine if online therapy can be as beneficial as face-to-face sessions. Ideal candidates are those who experienced a stroke affecting the left side of the brain at least a year ago and primarily speak English. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve access to effective therapy for others with similar conditions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these therapy methods are safe for aphasia treatment?

Research has shown that both sound-focused and meaning-focused therapy tasks are generally safe for people with aphasia. These therapies are well-known and have been used to improve language skills after a stroke.

Studies have found that phonological components analysis, a part of sound-focused therapy, is a popular method for helping people find words more easily. Strong evidence supports its use, and it has been applied successfully without reports of serious side effects.

Similarly, semantic feature analysis, a meaning-focused therapy, is widely used. It aids people with aphasia by concentrating on the meanings of words. This technique is well-tolerated and has shown positive results in improving language abilities.

Overall, these therapies are considered safe and effective for those seeking to improve their speech and language skills after a stroke. No significant adverse events are commonly associated with these treatments.12345

Why are researchers excited about this trial?

Researchers are excited about these speech-language therapy methods for aphasia because they offer a fresh approach to rehabilitation. Unlike traditional in-person therapy sessions, the Aphasia Remote Therapy (ART) allows participants to engage in treatment from home, using an online platform and teletherapy kits, which could make therapy more accessible and convenient. Meanwhile, the In-Clinic Therapy (I-CT) maintains the standard face-to-face interaction, ensuring comprehensive support from a speech-language pathologist. Both treatments uniquely combine semantically and phonologically-focused tasks, potentially enhancing the effectiveness of therapy by targeting different language processing areas. By examining the order and setting of these treatments, researchers hope to uncover optimal strategies for improving communication in people with aphasia.

What evidence suggests that this trial's treatments could be effective for aphasia?

Research has shown that two types of therapy tasks can help people with aphasia improve their ability to find words and communicate. In this trial, participants will receive both types of therapy. One type, Phonological Components Analysis, focuses on the sounds in words. This method helps people find words by breaking them down into individual sounds, and studies have shown it can greatly improve naming skills. The other type, Semantic Feature Analysis, focuses on the meanings of words. This approach helps by having people describe the features of words, and it has been effective in improving naming difficulties. Both therapy methods have shown promise in aiding recovery from aphasia.16789

Who Is on the Research Team?

JF

Julius Fridriksson, Ph.D

Principal Investigator

University of South Carolina

Are You a Good Fit for This Trial?

This trial is for English-speaking adults aged 21-80 who've had a left hemisphere stroke at least a year ago and can consent to treatment. They must be MRI compatible without metal implants or claustrophobia, and have no history of other brain diseases or severe speech/comprehension impairments.

Inclusion Criteria

I am between 21 and 80 years old.
Participants must be magnetic resonance imaging (MRI) compatible (e.g., no metal implants, not claustrophobic) on a 3-Tesla (3T) scanner.
I can give my own consent or appoint someone to do it for me.
See 2 more

Exclusion Criteria

I have no history of brain injuries or neurological diseases.
I have not had a stroke affecting both sides of my brain or in the cerebellum or brainstem.
I can speak and understand well enough to participate in therapy.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 3 weeks of daily semantically-focused treatment and 3 weeks of daily phonologically-focused treatment, either remotely or in-clinic

6 weeks
Daily sessions (remote or in-person)

Follow-up

Participants are monitored for changes in speech production and quality of life after treatment

6 months
Follow-up assessments at 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Phonologically-focused therapy tasks
  • Semantically-focused therapy tasks
Trial Overview The TERRA study compares two types of speech-language therapy for aphasia after a stroke: one delivered remotely (ART) and the other in-clinic (I-CT). It aims to see if telerehabilitation is as effective as traditional methods.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Aphasia Remote Therapy (ART)Experimental Treatment2 Interventions
Group II: In-Clinic Therapy (I-CT)Active Control2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of South Carolina

Lead Sponsor

Trials
233
Recruited
122,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Medical University of South Carolina

Collaborator

Trials
994
Recruited
7,408,000+

Published Research Related to This Trial

In a study involving three chronic aphasia speakers, Phonological Cueing Treatment (PCT) and Semantic Cueing Treatment (SCT) were tested for their effectiveness in improving action naming, with positive results for some participants.
Action naming improved for Speaker 1 (who received SCT) and Speaker 3 (who received both treatments), indicating that these cueing treatments can be beneficial for certain individuals with aphasia, though results may vary depending on the type of treatment and the grammatical category of the words.
Effects of two lexical retrieval cueing treatments on action naming in aphasia.Wambaugh, JL., Doyle, PJ., Martinez, AL., et al.[2009]
In a study of 104 individuals with chronic post-stroke aphasia, semantically focused treatment was found to be more effective than phonologically focused treatment for improving naming performance, regardless of treatment order.
Participants with milder speech impairments and fluent speech were more likely to respond positively to semantic treatment, while those with more severe impairments and apraxia of speech benefited more from phonological treatment.
Individualized response to semantic versus phonological aphasia therapies in stroke.Kristinsson, S., Basilakos, A., Elm, J., et al.[2022]
Semantic feature analysis is an effective intervention for improving naming abilities in individuals with aphasia, as shown by a review of 11 studies that utilized single subject research designs.
While most participants showed a small effect size using Cohen's d, a large treatment effect was observed when calculating the percent of non-overlapping data, indicating significant improvements in confrontational naming for many individuals.
The effectiveness of semantic feature analysis: an evidence-based systematic review.Maddy, KM., Capilouto, GJ., McComas, KL.[2018]

Citations

A systematic review of Phonological Components Analysis ...Among the wide range of anomia treatments for persons with aphasia (PWA), Phonological Components Analysis (PCA) is a well-known alternative.
Predicting Outcomes of Language RehabilitationAphasia severity, age, education, time postonset, and cognitive reserve predict naming gains at 1 week, 1 month, and 6 months posttherapy.
NCT04682223 | Telerehabilitation for Aphasia (TERRA)Speech-language therapy is generally found to be helpful in the rehabilitation of aphasia. However, not all patients with aphasia have access to adequate ...
The Phonomotor Approach to Treating Phonological-Based ...The phonomotor treatment program for treating word-retrieval deficits among people with aphasia is inspired by a parallel distributed processing model of ...
Phonological Components Analysis for AphasiaPhonological components analysis is an evidence-based speech therapy technique to improve word-finding in aphasia. Learn how with a free download.
Current Approaches to the Treatment of Post-Stroke AphasiaSupported by evidence from Phase III trials and large meta-analyses, it is now generally accepted that aphasia therapy can improve language processing for many ...
A systematic review of Phonological Components Analysis ...SFA enhances lexical retrieval by training persons with aphasia to generate and reflect on semantic attributes related to target words, ...
Phonological Components Analysis: A Step-By-Step GuideIn this article, you'll find a step-by-step guide to phonological component analysis for speech therapy, with charts and examples.
9.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40015347/
A systematic review of Phonological Components Analysis ...Among the wide range of anomia treatments for persons with aphasia (PWA), Phonological Components Analysis (PCA) is a well-known alternative.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security